AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells. - Sakemura RL; Hefazi M; Cox MJ; Siegler EL; Sinha S; Hansen MJ; Stewart CM; Feigin JM; Manriquez Roman C; Schick KJ; Can I; Tapper EE; et al. (Cancer immunology research, 2023)